Press Release

Pars’ Very First Corporate Funding Grant From Gilead Sciences

May 2, 2018

We are pleased to announce our very first Corporate funding grant from Gilead Sciences in the amount of $50,000 to support 40 immigrants and refugees with their Career Pathways.  We would like to thank the entire Gilead organization on behalf of Pars Equality Center for their support and trust.  Gilead’s commitment to medical innovation, providing access to medicines worldwide, and support of social service and community programs is exceptional, inspiring, and truly unparalleled. We would also like to recognize and thank Dr. Reza Oliyai, Senior Vice President of Pharmaceutical and Biologics Development, at Gilead Sciences for his dedication and guidance.